EDSA Stock Soars 200% as FDA Approves Dermatitis Study
EDSA stock investors are enjoying today’s ride after the FDA said that Edesa Biotech Inc (NASDAQ:EDSA) could go ahead with its clinical study of a potential new treatment for dermatitis. Big News for EDSA Stock ... [Read]